Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125362
Filing Date
2024-11-12
Accepted
2024-11-12 16:08:27
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q krro-20240930.htm   iXBRL 10-Q 2547573
2 EX-10.1 krro-ex10_1.htm EX-10.1 831255
3 EX-10.2 krro-ex10_2.htm EX-10.2 306197
4 EX-10.3 krro-ex10_3.htm EX-10.3 84329
5 EX-10.4 krro-ex10_4.htm EX-10.4 166971
6 EX-31.1 krro-ex31_1.htm EX-31.1 17694
7 EX-31.2 krro-ex31_2.htm EX-31.2 17576
8 EX-32.1 krro-ex32_1.htm EX-32.1 10079
  Complete submission text file 0000950170-24-125362.txt   10395146

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krro-20240930.xsd EX-101.SCH 1414524
81 EXTRACTED XBRL INSTANCE DOCUMENT krro-20240930_htm.xml XML 1185827
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 241448106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)